Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery
September 19 2017 - 11:00AM
Business Wire
Strategic Sponsorship Will Provide Innovative Technology and
Nurture Promising Biotechnology Startup
Agilent Technologies Inc. (NYSE: A) has announced a platinum
sponsorship agreement with LabCentral, a biotech innovation hub
based in Cambridge, Massachusetts. LabCentral is an independent,
shared laboratory space designed as a launchpad for high-potential
life sciences and biotech startups.
As a platinum sponsor, Agilent will equip LabCentral’s shared
laboratory workspace with a variety of Agilent technology.
Instruments will include a high-resolution mass spectrometry
system, as well as a cell analysis extracellular flux (XF)
analyzer. Also, Agilent will fund a high-potential biotech startup
company at LabCentral via a contest to award a Golden Ticket. The
Agilent-sponsored Golden Ticket is good for one individual bench in
LabCentral’s shared facility for one year. Online applications for
the Golden Ticket open on October 2, 2017, and will be accepted
until November 1, 2017, at 12:00 Noon PST. The finalists will
present to an esteemed review panel at a public event at LabCentral
on November 16, 2017. Learn more at
http://www.agilent.com/en/promotions/goldenticket.
“Agilent is committed to supporting the next generation of
scientific pioneers, and what better place to do so than in one of
our nation’s fastest growing biotech communities,” said Darlene
Solomon, senior vice president and chief technology officer for
Agilent. “We couldn’t be more proud to offer our technologies to
LabCentral residents, and our support to emerging biotech to help
accelerate innovation in critical areas that can improve human
health.”
“We’re honored to welcome Agilent as a platinum sponsor, which
will enable us to build out significant extra analytical capacity
for our startups to use,” said Johannes Fruehauf, M.D., Ph.D.,
cofounder, and president for LabCentral. “In addition, we are
especially happy that Agilent has agreed to become a Golden Ticket
sponsor. The team has come up with an exciting process for
identifying the winner, and I look forward to participating.”
LabCentral offers a supportive and nurturing environment
designed to inspire interaction and collaboration. Startups work
side by side on some of the most exciting potential breakthroughs
in diagnostics and therapeutics, and prevention — across the
spectrum of diseases.
Biopharma is a fast-growing market for Agilent, and Cambridge is
a hub of innovation in this field.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics, and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to its
customers’ most challenging questions. The company generated
revenues of $4.20 billion in fiscal 2016 and employs about 13,000
people worldwide. Information about Agilent is available at
www.agilent.com.
About LabCentral (www.labcentral.org; twitter
@labcentral)
LabCentral is a first-of-its-kind shared laboratory workspace in
the heart of the Kendall Square, Cambridge, biotech innovation hub.
Designed as a launchpad for high-potential life-sciences and
biotech startups, it offers everything startups need to begin
laboratory operations on day one and move their science forward
faster and more cost-efficiently. This includes: fully permitted
laboratory and office space, first-class facility and
administrative support, skilled laboratory personnel, a
domain-relevant expert speaker series ‒ as well as the other
critical services and support. A private, nonprofit institution,
LabCentral’s first site opened in 2013, thanks to a capital grant
from the Massachusetts Life Sciences Center, with support from its
real-estate partner, MIT. Founding sponsors include Triumvirate
Environmental and Johnson & Johnson Innovation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170919005400/en/
Agilent Technologies, Inc.Naomi Goumillout,
+1-781-266-2819naomi.goumillout@agilent.comorLabCentralCaroline A.
Grossman +1-781-771-5579cgrossman@labcentral.org
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024